OrbiMed Advisors LLC's Form 4 filing
Verona Pharma plc (VRNA) · filed May 15, 2023
- Accession no.
- 0000947871-23-000586
- Filed
- May 15, 2023, 6:07 PM ET
- Trade date
- May 11-15, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $9.94M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director |
| OrbiMed Capital GP VI LLCCIK 0001682115 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 11, 2023 | Ordinary Shares | SSaleDisposed | −80,000 | $22.26 | −$1,780,800 | 4,180,691 | Indirect | Duplicate filing |
| May 12, 2023 | Ordinary Shares | SSaleDisposed | −43,200 | $21.64 | −$934,848 | 4,137,491 | Indirect | Duplicate filing |
| May 15, 2023 | Ordinary Shares | SSaleDisposed | −14,400 | $21.96 | −$316,224 | 4,123,091 | Indirect | Duplicate filing |
| May 15, 2023 | Ordinary Shares | SSaleDisposed | −345,313 | $20.00 | −$6,906,260 | 3,777,778 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.